| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000020779 |
| Receipt No. | R000023981 |
| Official scientific title of the study | A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity. |
| Date of disclosure of the study information | 2016/02/01 |
| Last modified on | 2018/08/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity. | |
| Title of the study (Brief title) | A study for evaluating effects of ingested amino acids, cystine and theanine, on postoperative amount of activity. | |
| Region |
|
|
| Condition | ||
| Condition | Open distal gastrectomy | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To study whether preoperative administration of amino acids, cystine and theanine, accelerate recovery from postoperative reduction of activity amount. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Changes in amount of activity from 2 days before to 1 week after surgery measured using wristwatch-type motion logger. |
| Key secondary outcomes | Hematological and blood biochemistry indices before and 1, 3, 7, 14days after surgery. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of supplement containing 700mg of cystine and 280mg of theanine once daily for 10 days from 2days before until 7days after surgery. | |
| Interventions/Control_2 | No ingestion of supplement instead of the cystine and theanine. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Received a written informed consent by patient's self-determination.
2.Scheduled to receive open distal gastrectomy. 3.From 20 to less than 80 years old. 4.No severe complication before surgery. |
|||
| Key exclusion criteria | 1.Phenyl ketonuria.
2.Active infection. 3.Poorly controlled hypertension. 4.Poorly controlled diabetes. 5.Clinically important cardiac disease. 6.Severe pulmonary disease(e.g. interstitial pneumonia, fibrosis, severe emphysema). 7.History of clinically important psychopathic disorder or central nervous system damage. 8.Continuous systemic administration(iv or po) of steroid. 9.Pregnancy, breast-feeding, possible pregnancy, and willing to be pregnant. 10.Particpation for other studies. 11.Impossible of oral ingestion. 12.Judged ineligible by the principal investigator of sub-investigator. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Tsuchiya |
| Organization | Sendai City Medical Center Sendai Open Hospital |
| Division name | Director, GI Surgery |
| Address | 5-22-1 Tsurugaya , Miyagino-ku, Sendai City, Miyagi |
| TEL | 022-252-1111 |
| tsuchiya@openhp.or.jp | |
| Public contact | |
| Name of contact person | Takashi Tsuchiya |
| Organization | Sendai City Medical Center Sendai Open Hospital |
| Division name | Director, GI Surgery |
| Address | 5-22-1 Tsurugaya , Miyagino-ku, Sendai City, Miyagi |
| TEL | 022-252-1111 |
| Homepage URL | |
| tsuchiya@openhp.or.jp | |
| Sponsor | |
| Institute | Sendai City Medical Center Sendai Open Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ajinomoto Co., Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023981 |